Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Federal Trade Commission
Queensland Health
Covington
Chubb
McKesson
Colorcon
QuintilesIMS
Harvard Business School

Generated: June 23, 2018

DrugPatentWatch Database Preview

TIAGABINE HYDROCHLORIDE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Drug patent expirations by year for TIAGABINE HYDROCHLORIDE
Pharmacology for TIAGABINE HYDROCHLORIDE
Synonyms for TIAGABINE HYDROCHLORIDE
(-)-(R)-1-(4,4-bis(3-methyl-2-thienyl)-3-butenyl)nipecotic acid hydrochloride
(-)-(R)-1-(4,4-Bis(3-methyl-2-thienyl)-3-butenyl)nipecotic acid, hydrochloride
(-)-(R)-1-[4,4-Bis(3- methyl-2-thienyl)-3-butenyl]nipecotic acid hydrochloride
(-)-(R)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]nipecotic acid hydrochloride
(3R)-1-[4,4-Bis(3-methyl-2-thienyl)-3-buten-1-yl]-3-piperidinecarboxylic acid hydrochloride
(3R)-1-[4,4-Bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylic Acid Hydrochloride
(3R)-1-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]-3-carboxypiperidinium chloride
(3R)-1-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]piperidine-3-carboxylic acid hydrochloride
(3R)-1-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]piperidine-3-carboxylic acid monohydrochloride
(3R)-1-[4,4-bis(3-methyl-2-thienyl)but-3-enyl]piperidine-3-carboxylic acid hydrochloride
(3R)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-en-1-yl]piperidine-3-carboxylic acid hydrochloride
(3R)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-enyl]piperidine-3-carboxylic acid hydrochloride
(3R)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-enyl]piperidine-3-carboxylic acid;hydrochloride
(r)-1-(4,4-bis(3-methylthiophen-2-yl)but-3-en-1-yl)piperidine-3-carboxylic acid hydrochloride
145821-59-6
3-Piperidinecarboxylic acid, 1-(4,4-bis(3-methyl-2-thienyl)-3-buten-yl)-, hydrochloride, (R)-
3-Piperidinecarboxylic acid, 1-(4,4-bis(3-methyl-2-thienyl)-3-butenyl)-, hydrochloride, (R)-
4CH-019728
A-70569
Abbott 70569.HCl
Abbott-70569.1
ABBOTT-70569.HCL
ABT 569
ABT-569
AC1L3LR1
AK155448
AKOS024258856
AN-31388
API0004405
AX8154082
BG0438
C20H25NO2S2.HCl
C20H26ClNO2S2
CAS-145821-59-6
CCG-100885
CEP-6671
CHEBI:85388
CHEMBL1695
CPD000469176
CS-2937
D02097
DQH6T6D8OY
DSSTox_CID_24218
DSSTox_GSID_44218
DSSTox_RID_80125
DTXSID2044218
EN300-221591
FT-0675216
Gabitril
Gabitril hydrochloride
H03T543
HY-B0696A
J-008159
KB-308664
KS-00000H6B
KS-1217
LS-173258
MFCD07369025
MLS001401367
MolPort-006-069-142
NC00135
NCGC00164626-01
NCGC00164626-02
NN-301
NNC-05-0328
NO-05-0328
NO050328 hydrochloride
NO328 hydrochloride
s4661
SAM001246625
SCHEMBL41860
SMR000469176
ST2402069
TGB hydrochloride
Tiabex
Tiagabine (hydrochloride)
TIAGABINE HCl
Tiagabine hydrochloride (USP)
Tiagabine hydrochloride [USAN:USP]
Tiagabine hydrochloride [USAN]
Tiagabine Hydrochloride 1.0 mg/ml in Methanol (as free base)
Tiagabine hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material
Tiagabine hydrochloride, >=98% (HPLC)
tiagabine monohydrochloride
Tiagabinehydrochloride
Tox21_112245
Tox21_112245_1
UNII-DQH6T6D8OY
VC30712
YUKARLAABCGMCN-PKLMIRHRSA-N
Z2216208631

US Patents and Regulatory Information for TIAGABINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms Co TIAGABINE HYDROCHLORIDE tiagabine hydrochloride TABLET;ORAL 208181-001 Dec 8, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Wilshire Pharms Inc TIAGABINE HYDROCHLORIDE tiagabine hydrochloride TABLET;ORAL 206857-001 Oct 13, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Amneal Pharms Co TIAGABINE HYDROCHLORIDE tiagabine hydrochloride TABLET;ORAL 208181-004 Dec 8, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Wilshire Pharms Inc TIAGABINE HYDROCHLORIDE tiagabine hydrochloride TABLET;ORAL 206857-002 Oct 13, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Express Scripts
Cantor Fitzgerald
UBS
Farmers Insurance
Queensland Health
Cerilliant
Cipla
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.